|
⚲
|
| Keyboard |
| Kent McGaughy | |
|---|---|
| Firm | |
| Address | 4514 Cole Avenue Suite 1650 Dallas, TX 75205 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Griffin Highline Capital LLC | 021-509489 | Director | 1.1 M of 10.0 M |
||
| Griffin Highline Capital LLC | 021-501047 | Director | 10.6 M of 25.0 M |
||
| Griffin Highline Capital LLC | 021-410704 | Director | 90.8 M | ||
| Instil Bio Inc | 021-390158 | Director | 185.4 M of 185.4 M |
||
| Instil Bio Inc | 021-372567 | Director | 0.5 M of 0.5 M |
||
| Instil Bio Inc | 021-372568 | Director | 170.2 M of 170.2 M |
||
| Instil Bio Inc | 021-349980 | Director | 25.0 M of 25.0 M |
||
| Mandiant Corp | 021-163314 | Director | 70.0 M of 70.0 M |
||
| Reata Pharmaceuticals Inc | 021-162812 | Director | 300.0 M of 300.0 M |
||
| Reata Pharmaceuticals Inc | 021-148582 | Director | 17.0 M of 79.3 M |
||
| Reata Pharmaceuticals Inc | 021-88081 | Director | 2.0 M of 2.0 M |
||